United States · 
What does Casdin Capital invest in?
Casdin Capital invests most often at Series B and Series A (69% of the rounds on record), in sectors such as Health, Healthier Living and Digital-health.
Casdin Capital highlights
- 01
8 cheques in the last 12 months
- 02
Mostly Series B and Series A: 69% of its rounds
- 03
Sole investor in 5 rounds, median $8.1M
- 04
2 exits from the portfolio
What they do
Filed 2 private fund offerings with the SEC, the most recent in 2021-11From their own website
- Type
- VC firm (from a list, unverified)
- Cheque size
- $100K – $5.0M as they say
- Stages
- SeedSeries ASeries BGrowthPre-IPO
- Sectors
- HealthHealthier LivingDigital-health
- Based in
- New York, United States
- Cold pitches
- Not stated
The record
Every round we can evidence, newest first104 appearances
- 2026
6 rounds
- Oct
- Jun
- Jun
- Apr
- Jan
- Jan
- 2025
13 rounds
- Dec
- Nov
- Oct
- Aug
- Aug
- Aug
- Jul
- Jul
- May
- Apr
- Jan
- Jan
- Jan
- 2024
15 rounds
- Dec
- Dec
- Sept
- Sept
- Sept
- Aug
- Aug
- Jul
- Jul
- Jun
- May
- Apr
- Apr
- Jan
- Jan
- 2023
7 rounds
- Dec
- Jun
- Apr
- Apr
- Mar
- Mar
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
The team
Named by the firm itself, on a filing, its Form ADV or its company registration5 named
AFAlexandria FiskChief Operating OfficeriForm ADV
ACAngelo CrupiChief Compliance OfficeriForm ADV
EDEli D CasdinManaging Member of the General PartneriFiling they signed
LJLawrence Jude CanzoneriChief Financial OfficeriForm ADV
SMSteven Michael GiordanoGeneral CounseliForm ADV
We also hold 21 people at this firm from the lists this database was built from: a weaker source than the filings, since a list does not say when a title ended. Login to see them.
What the register says
From the firm's own filings with the SEC, which it must file accurately by law
$2.9Bassets it managesOct 2026
Registeredinvestment adviserfull reporting to the SEC
- Legal name
- Casdin Capital, LLC
- SEC number
- CRD 169579
Funds on its Form ADV
6 private funds, $2.6B in gross assets · filed Mar 2024
Hedge 3Private equity 2Venture 1
- Casdin Partners Master Fund, L.P.Hedge563 investors$1.9B
- Casdin Private Growth Equity Fund II, L.P.Private equity226 investors$402M
- Casdin Private Growth Equity Fund, L.P.Private equity175 investors$243M
- Casdin Venture Opportunities Fund, L.P.Venture46 investors$29M
- Casdin Partners FO1 - MSV, L.P.Hedge2 investors$25M
- Casdin Amplify Fund, L.P.Hedge2 investors$14M
Exits from the portfolio
Companies it backed that were later bought or listed2 in all
Foundation MedicineBought by RocheUndisclosedJan 2015
Foundation MedicineListed$108MJul 2013
An exit counts when it came after the firm's first round in the company. From historical deal records.